Recorlev (levoketoconazole), Strongbridge Biopharma's oral investigational therapy for endogenous Cushing's syndrome, resulted in sustained improvements in cortisol and glycemic control in patients with Cushing...
SATURDAY, February 20, 2021 (HealthDay News) - Diabetes is never easy to manage, but managing type 1 diabetes can be an especially difficult challenge...